Biotechnology News

August 20, 2014

PLEASANTON, Calif.--(BUSINESS WIRE)--Pharma Start improves audit readiness with paperless eTMF solution from Veeva Systems.

August 20, 2014

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: NeuroVive’s research wins award at international research symposium Second Quarter (1 Apr. 2014 – 30 Jun. 2014) -- Net revenues were SEK 0 (5,335,000) and other operating income was SEK 1,128,...

August 20, 2014

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: CEO’s comments: "We have achieved strong profitability for the first half of the year with an operating margin of 29 % excluding license revenue from Nestlé. Including license revenue from...

August 20, 2014

NOTTINGHAM, England--(BUSINESS WIRE)--Source BioScience plc (LSE:SBS) the international laboratory services and products business publishes its Half Year Report for the six months ended 30 June 2014. Financial highlights Revenue increased by 46%...

August 20, 2014

BURTON-ON-TRENT, England--(BUSINESS WIRE)--Clinigen Group plc the specialty global pharmaceutical company today announces the acquisition of the global rights to the oncology support therapy, Ethyol® (amifostine) from AstraZeneca.

August 19, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix (Nasdaq: OCUL) IPO underwriters exercised in full their over-allotment option to purchase an additional 750,000 shares, resulting in gross proceeds of approximately $74.8 million.

August 19, 2014

CHICAGO & LOS ALTOS, Calif.--(BUSINESS WIRE)--Igenbio, Inc., a Chicago based genome analysis company, announced today that they entered into a collaborative agreement with Genome Compiler Corp., a Los Altos based synthetic biology software...

August 19, 2014

ROCKVILLE, Md. & MUNICH & MARTINSRIED, Germany--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) and MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) today announced an agreement for the joint development and...

August 19, 2014

DENVER--(BUSINESS WIRE)--Colorado BioScience Association (CBSA) will hold its BioWest Conference, September 10, 2014, at the Marriott City Center, Denver.

August 19, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--FDA approves Cerdelga™ (eliglustat) capsules as the only first-line oral therapy for certain adult Gaucher disease type 1 patients

August 19, 2014

OPELIKA, Ala.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) announced today that it plans to expand its state-of-the-art manufacturing facility in Opelika, Ala., to help address the growing global demand for dialyzers, a critical...

August 19, 2014

LEWISVILLE, Texas--(BUSINESS WIRE)--As previously disclosed, Orthofix International N.V. (NASDAQ: OFIX) (the “Company”) has been evaluating the accounting treatment applied to certain entries included in the previous restatement of its prior...

August 19, 2014

EPALINGES, Switzerland--(BUSINESS WIRE)--Pre-clinical mouse study data from Stemedica International shows over 30-percent decrease in amyloid beta plaques when treating Alzheimer's disease with ischemia-tolerant mesenchymal stem cells

August 19, 2014

BETHESDA, Md.--(BUSINESS WIRE)--Cannabics Pharmaceuticals recruits 2 TEVA executives.

August 19, 2014

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical recalled its CloverSnare vascular retrieval snare after six reports of tip separation.

August 19, 2014

CLEVELAND--(BUSINESS WIRE)--Human tissues are extensively employed by pharmaceutical and academic researchers to identify and validate new biomarkers and drug discovery targets. Such tissues are also widely used to study the efficacy,...

August 19, 2014

BOULDER, Colo.--(BUSINESS WIRE)--SomaLogic, Inc., announced today that Massachusetts General Hospital (MGH) will be the first Boston-area biomedical research center to perform on-site studies using the SOMAscan™ proteomics assay.

August 19, 2014

CARLSBAD, Calif. & BOSTON--(BUSINESS WIRE)--The seventh annual BioPharm America™ international life science partnering conference, held September 22–24 in Boston, is a big draw for pharma and investors who want to access innovative biotech...

August 19, 2014

GENEVA & BOSTON--(BUSINESS WIRE)--Medimaps Group appoints Hologic, Inc. as USA Distribution Partner for TBS iNsight® – a Novel Osteoporotic Fracture Assessment Diagnostic Tool

August 19, 2014

HOUSTON--(BUSINESS WIRE)--NuPhysicia, Inc., becomes an approved PEMEX supplier. NuPhysicia is the only telemedicine technology and services company to receive this approval by Pemex Procurement International.

August 19, 2014

TAMPA, Fla.--(BUSINESS WIRE)--What would be possible if every American had access to patient-centered, consumer-driven, and value-based healthcare? The Oliver Wyman Health Innovation Center (OWHIC) and the Tampa Hillsborough Economic Development...

August 19, 2014

BOSTON--(BUSINESS WIRE)--WEGO Health Network Tops 100,000 Patient Influencer Members; Online Leaders Reach Critical Mass, Driving the Patient-Centered Revolution

August 19, 2014

ALACHUA, Fla.--(BUSINESS WIRE)--Nanotherapeutics, Inc., an integrated biopharmaceutical company with a focus on development and manufacturing, announced today the opening of a new, 4,800 square foot office, located at 8490 Progress Drive, Suite...

August 19, 2014

BOSTON--(BUSINESS WIRE)--Hemenway & Barnes LLP, one of Boston’s most storied legal and fiduciary firms, today issued a new discussion paper, “The next cycle of earners: three keys to safeguarding new wealth” The paper explores ways for the...

August 19, 2014

NORTHBROOK, Ill.--(BUSINESS WIRE)--Marathon Pharmaceuticals, LLC today announced Babar Ghias has joined the company as vice president of corporate development.

August 19, 2014

MADISON, Wis.--(BUSINESS WIRE)--Promega announces its expansion into India with a 16th branch that serves the country’s scientific community with wide product availability, efficient delivery and technical support services.

August 19, 2014

BOCA RATON, Fla.--(BUSINESS WIRE)--Akron Biotech Named 2014 Florida Companies to Watch Winner

August 19, 2014

MIRAMAR, Fla.--(BUSINESS WIRE)--Altor BioScience Corporation (Altor), a leading developer of cancer immunotherapies, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase II grant by the National Cancer...

August 19, 2014

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Spencer Falk, whose marketing expertise was mission-critical to the blockbuster success of Viagra and Celebrex, among other medical brands, today announced that he would lead the commercialization of early...

August 19, 2014

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the availability of the informaSeq Prenatal Test. The informaSeq Prenatal Test is an advanced, non-invasive, next-generation...

August 19, 2014

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Sparton Corporation to Present at Midwest IDEAS Investor Conference 2014 held on Tuesday August 26, 2014 at the Hard Rock Hotel in Chicago.

August 19, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Spero Therapeutics to present data at upcoming ICAAC meeting showing activity of MvfR inhibitors to combat resistant bacteria; potential for whole new treatment approach.

August 19, 2014

SAN DIEGO--(BUSINESS WIRE)--Combined value of contract potentially $20.4 M: $12.1 M for activities leading to IDE approval for clinical trial, and an anticipated $8.3 M to cover costs associated with clinical trial

August 19, 2014

MORRISTOWN, N.J. & HONOLULU--(BUSINESS WIRE)--Capsugel and Cardax announce collaboration to develop proprietary astaxanthin products for the consumer health market with lipid-based formulations for improved oral bioavailability.

August 19, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--2014 MichBio Expo & Conference to feature keynote by FDA Commissioner Margaret A. Hamburg, MD.

August 19, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Dermira, a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products to dermatologists and their patients, today announced that it has completed a $51...

August 19, 2014

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT:CVM) today announced its Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine* (Leukocyte Interleukin, Injection) has added...

August 19, 2014

DURHAM, N.C.--(BUSINESS WIRE)--Novan Therapeutics, a clinical-stage biotech company focused on advancing nitric oxide therapies, announced today that the Company’s Nitricil™ platform technology has been shown to be efficacious against several of...

August 19, 2014

SUMMIT, N.J.--(BUSINESS WIRE)--STUDY IN THE JOURNAL OF CLINICAL ONCOLOGY REPORTS PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RECEIVING ORAL REVLIMID WITH STANDARD R-CHOP ACHIEVED 98% OVERALL RESPONSE RATE AND 80% COMPLETE

August 19, 2014

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced that it has received notice of the early termination of the waiting period for U.S. antitrust review under the Hart-Scott-Rodino Antitrust Improvements Act...

August 19, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announced that it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical trial with BRILINTA® (ticagrelor) tablets....

August 19, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US/Non-UK/Non-Canadian Media Boehringer Ingelheim today announces that the first patients have been enrolled in the company’s new international phase III study, RE-DUAL PCITM.1 The study will evaluate...

August 19, 2014

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Probi (STO:PROB) SECOND QUARTER OF 2014 •NET SALES amounted to MSEK 31.9 (26.5). •OPERATING PROFIT totalled MSEK 5.3 (4.6). •PROFIT AFTER TAX amounted to MSEK4.3 (3.8). •PROFIT AFTER TAX PER SHARE...

August 18, 2014

SAN DIEGO--(BUSINESS WIRE)--Using a fundraising approach seldom seen in the life sciences sector, Batu Biologics, an immunotherapy company working to develop the first anti-angiogenic cancer vaccine, has successfully raised $100,000 through the...